# OnCo record vicky-makker (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/vicky-makker/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "vicky-makker" ;
  schema:name "Vicky Makker"@en ;
  schema:description "New York oncologist who led KEYNOTE-775, the trial that established lenvatinib plus pembrolizumab for advanced endometrial cancer after chemotherapy."@en ;
  schema:url <https://onco.cc/people/vicky-makker/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "endometrial", "gynaecological", "immunotherapy", "trialist" ;
  schema:jobTitle "Gynaecologic medical oncologist, Memorial Sloan Kettering Cancer Center" ;
  onco:cancers <https://onco.cc/cancers/advanced-recurrent-endometrial-cancer/>, <https://onco.cc/cancers/endometrial/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-keynote-775-nejm-2022/> ;
  schema:affiliation <https://onco.cc/institutions/mskcc/> .